Our Approach


Next Generation Medicine through Interrogative Biology®, powered by bAIcis®

The contrast between health and disease guides our discoveries and innovations. We call this going ‘Back to Biology.

Our ‘Back to Biology approach is driven by our Interrogative Biology® platform that combines patient information with our proprietary AI-based machine-learning analytics program (bAIcis®) to transform patient data into potential drug targets, biomarkers and predictive models.

The Interrogative Biology® platform in turn guides our Next Generation Medicine program that encompasses a portfolio of assets, including novel therapeutics, biomarker panels and diagnostic technologies, a data repository and a sample bank.

Next Generation Medicine through Interrogative Biology®, powered by bAIcis®

Patient blood, serum and tissue samples are processed by high-throughput mass spectrometry. This enables the multi-omic characterization of each sample, allowing us to gain snapshots of the human body in both health and disease. Data are then contextualized with patient demographic and clinical information and analyzed by bAIcis®, our proprietary AI-based machine-learning analytics program that infers Bayesian networks from our inputs to produce hub maps identifying potential cause-and-effect relationships. This unrivaled and unbiased method of profiling not only exposes therapeutically targetable aberrations, but also allows for the stratification of patients for predictive modeling.

BERG Analytics and Patient Intelligence

  • BERG Analytics aims to provide real-time analytic solutions that predict the impact of treatment plans at the individual level to optimize population health strategies.
  • Our Patient Intelligence, brought about by our Interrogative Biology® program and bAIcis®, will drive this population-level efficiency.

For more information on BERG Analytics healthcare analytic solutions visit: analytics.berghealth.com